Endocrine late effects of cancer treatment

Laurie E. Cohen

doi:10.1016/j.ecl.2005.04.008

Endocrine late effects of cancer treatment

Laurie E. Cohen

Research output: Contribution to journal › Review article › peer-review

44 Scopus citations

Abstract

Endocrine sequelae are common in cancer survivors. Incidence and prevalence rates over time remain difficult to interpret because of small study sizes and variable treatment regimens. Nevertheless, patients at risk of developing endocrinologic sequelae can be identified and followed carefully so that treatment, when necessary, is provided in a timely manner and morbidity is minimized or prevented.

Original language	English (US)
Pages (from-to)	769-789
Number of pages	21
Journal	Endocrinology and Metabolism Clinics of North America
Volume	34
Issue number	3
DOIs	https://doi.org/10.1016/j.ecl.2005.04.008
State	Published - Sep 2005
Externally published	Yes

ASJC Scopus subject areas

Endocrinology, Diabetes and Metabolism
Endocrinology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.ecl.2005.04.008

Cite this

@article{55dd22901685481f9de4b9cbffff49eb,

title = "Endocrine late effects of cancer treatment",

abstract = "Endocrine sequelae are common in cancer survivors. Incidence and prevalence rates over time remain difficult to interpret because of small study sizes and variable treatment regimens. Nevertheless, patients at risk of developing endocrinologic sequelae can be identified and followed carefully so that treatment, when necessary, is provided in a timely manner and morbidity is minimized or prevented.",

author = "Cohen, {Laurie E.}",

year = "2005",

month = sep,

doi = "10.1016/j.ecl.2005.04.008",

language = "English (US)",

volume = "34",

pages = "769--789",

journal = "Endocrinology and Metabolism Clinics of North America",

issn = "0889-8529",

publisher = "W.B. Saunders Ltd",

number = "3",

}

TY - JOUR

T1 - Endocrine late effects of cancer treatment

AU - Cohen, Laurie E.

PY - 2005/9

Y1 - 2005/9

N2 - Endocrine sequelae are common in cancer survivors. Incidence and prevalence rates over time remain difficult to interpret because of small study sizes and variable treatment regimens. Nevertheless, patients at risk of developing endocrinologic sequelae can be identified and followed carefully so that treatment, when necessary, is provided in a timely manner and morbidity is minimized or prevented.

AB - Endocrine sequelae are common in cancer survivors. Incidence and prevalence rates over time remain difficult to interpret because of small study sizes and variable treatment regimens. Nevertheless, patients at risk of developing endocrinologic sequelae can be identified and followed carefully so that treatment, when necessary, is provided in a timely manner and morbidity is minimized or prevented.

UR - http://www.scopus.com/inward/record.url?scp=23444457947&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23444457947&partnerID=8YFLogxK

U2 - 10.1016/j.ecl.2005.04.008

DO - 10.1016/j.ecl.2005.04.008

M3 - Review article

C2 - 16085170

AN - SCOPUS:23444457947

SN - 0889-8529

VL - 34

SP - 769

EP - 789

JO - Endocrinology and Metabolism Clinics of North America

JF - Endocrinology and Metabolism Clinics of North America

IS - 3

ER -

Endocrine late effects of cancer treatment

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this